NantHealth is continuously working to enhance GPS Cancer by incorporating the latest advancements in genomic and proteomic research. Future developments may include even more refined algorithms for data analysis and the integration of additional biomarkers. As the field of precision medicine continues to evolve, GPS Cancer is poised to remain at the forefront of personalized cancer treatment.